# Hydrogen and lung diseases: what the studies say

> Lung diseases and molecular hydrogen. The lungs are the first organ that inhaled hydrogen reaches. Symptoms, causes and human studies.

URL: https://pragmah2.com/en/hydrogen-and-health/lung-diseases/
Updated: 2026-11-20

[Hydrogen and health](https://pragmah2.com/en/hydrogen-and-health/) / Lungs and airways

The lungs are the first organ that inhaled hydrogen reaches. This is where the largest clinical trials of hydrogen have been carried out.

Hydrogen and lung diseases

We describe what was studied in humans and what the authors of the publications observed. We give the source for every study.

Typical symptoms

- breathlessness
- chronic cough
- wheezing
- tiring quickly

Studies

Human studies: 4 studies in the cards below, including 3 randomised.

On this page

- What are chronic lung diseases?
- Symptoms of lung diseases
- Studies
- Causes of lung diseases
- How lung diseases are diagnosed and treated
- Questions

## What are chronic lung diseases?

Chronic lung diseases such as COPD, asthma and interstitial diseases share breathlessness, cough and a gradual loss of capacity. Treatment is led by a pulmonologist, and pulmonary rehabilitation plays an important part.

### Symptoms of lung diseases

- Breathlessness on exertion, and in time at rest too
- A chronic cough, dry or with phlegm
- Wheezing
- Poorer exercise tolerance, tiring quickly
- Frequent respiratory infections

**When to see a doctor.** Coughing up blood, sudden breathlessness or chest pain call for urgent help. A cough lasting more than 8 weeks needs a chest X-ray.

## Lung diseases: what happens in the body

The lining of the airways comes into contact with smoke, dust and microbes. It responds with inflammation, in which free radicals destroy the air sacs and stimulate fibrosis.

During inhalation the airways are the first tissue hydrogen reaches. A hydrogen-oxygen mixture is also less dense than air; in studies the authors observed less effort of the breathing muscles with it. This area has some of the largest clinical trials of hydrogen.

[Watch the animation: what hydrogen does in the cell](https://pragmah2.com/en/how-hydrogen-works/#xmech)

## Hydrogen and lung diseases: the studies we refer to

In a multicentre trial in COPD exacerbations, the authors observed a greater fall in symptom severity with the hydrogen-oxygen mixture than with oxygen alone. In people with early interstitial lung disease, after 48 weeks of drinking hydrogen water the CT picture improved in 64% versus 40% of those treated with N-acetylcysteine. In people with silicosis who were given hydrogen in addition to a drug, the authors observed a better diffusing capacity of the lungs.

What the studies say

Selected scientific publications on molecular hydrogen in humans: a description of each study, its results and a link to the source.

**1 Exacerbation of COPD randomised trial n = 107 inhalation 2021**

- **Participants**: 108 randomised; 107 in the full analysis set
- **Protocol**: H2/O2 2:1 vs oxygen for 7 days, alongside standard treatment
- **Result**: BCSS fell by 5.3 vs 2.4 points; adjusted difference −2.75 points (95% CI −3.27 to −2.22). CAT score: −11 vs −6 points (p<0.001).
- **Study context**: RCT, 10 centres, double-blind. Participants: 107.

Zheng ZG i wsp.. *Hydrogen/oxygen therapy for the treatment of an acute exacerbation of chronic obstructive pulmonary disease: results of a multicenter, randomized, double-blind, parallel-group controlled trial*. Respiratory research 22(1): 149. 2021. [PubMed 33985501](https://pubmed.ncbi.nlm.nih.gov/33985501/) · [DOI](https://doi.org/10.1186/s12931-021-01740-w) · [Full text](https://pmc.ncbi.nlm.nih.gov/articles/PMC8120708/)

**2 Early interstitial lung disease Hydrogen water randomised trial n = 87 2023**

- **Participants**: 44 H2 and 43 NAC in the ITT analysis; 75 completed the protocol
- **Protocol**: 350 ml of H2 at 1.6 ppm 2× a day for 48 weeks vs NAC
- **Result**: More favourable CPI and DLCO. HRCT improvement: 63.6% vs 39.5% in the ITT analysis; among those completing the protocol 73.0% vs 39.5% (p=0.008).
- **Study context**: Randomised controlled trial. Participants: 87.

Tang C i wsp.. *Efficacy and Safety of Hydrogen Therapy in Patients with Early-Stage Interstitial Lung Disease: A Single-Center, Randomized, Parallel-Group Controlled Trial*. Therapeutics and clinical risk management 19: 1051-1061. 2023. [PubMed 38107500](https://pubmed.ncbi.nlm.nih.gov/38107500/) · [DOI](https://doi.org/10.2147/tcrm.s438044) · [Full text](https://pmc.ncbi.nlm.nih.gov/articles/PMC10723077/)

**3 Stage II silicosis randomised trial n = 108 inhalation 2026**

- **Participants**: 116 enrolled; 54 H2 + tetrandrine and 54 tetrandrine alone in the analysis
- **Protocol**: H2 as an addition to tetrandrine; comparison with the medicine alone
- **Result**: The combination improved the diffusing capacity of the lungs and breathlessness; IL-6 was lower than with the medicine alone (p<0.05).
- **Study context**: RCT, double-blind. Participants: 108.

Xiao K i wsp.. *The clinical efficacy of hydrogen combined with tetrandrine in the treatment of silicosis fibrosis: A randomized controlled intervention study*. Respiratory medicine 260: 108939. 2026. [PubMed 42250702](https://pubmed.ncbi.nlm.nih.gov/42250702/) · [DOI](https://doi.org/10.1016/j.rmed.2026.108939)

**4 Severe tracheal stenosis controlled study n = 35 inhalation 2018**

- **Participants**: In sequence: air, H2/O2, oxygen and H2/O2 again
- **Protocol**: H2/O2 2:1, 6 l/min; short periods and a 120-minute exposure
- **Result**: Diaphragm activity (EMGdi) fell from about 53% to 42.5% during H2/O2; diaphragmatic pressure decreased by an average of 4.77 cm H2O. The Borg score was also better.
- **Study context**: Prospective self-controlled study, fixed order of gases. Participants: 35.

Zhou ZQ i wsp.. *Breathing Hydrogen-Oxygen Mixture Decreases Inspiratory Effort in Patients with Tracheal Stenosis*. Respiration; international review of thoracic diseases 97(1): 42-51. 2018. [PubMed 30227423](https://pubmed.ncbi.nlm.nih.gov/30227423/) · [DOI](https://doi.org/10.1159/000492031)

Educational information, not medical advice. Full database of publications: [Hydrogen Studies](https://hydrogenstudies.com/dataset).

A broader review of the research: [Molecular hydrogen and COPD: what the studies show](https://pragmah2.com/en/knowledge-base/copd/), [Hydrogen and lungs exposed to dust: smog, pneumoconiosis, interstitial lung disease](https://pragmah2.com/en/knowledge-base/smog-silicosis/).

## Lung diseases: what to know

### Causes of lung diseases

- Smoking, including passive smoking
- Smog, and dust and fumes at work
- Allergies and genetic tendencies
- Recurrent or severe respiratory infections

### Living with a lung disease

Lung diseases take away what a healthy person never thinks about: breathing freely. First you have to stop on the stairs, then give up a walk, because breathlessness comes earlier and earlier.

### How lung diseases are diagnosed and treated

A lung specialist orders spirometry and imaging, and care depends on the diagnosis: inhaled medicines, pulmonary rehabilitation and, in advanced lung diseases, oxygen therapy. The most important step is always giving up smoking.

### What supports the body in lung diseases

- Giving up smoking and avoiding smoke
- Pulmonary rehabilitation and regular walking
- Vaccination against flu, pneumococcus and COVID-19

## Lung diseases and hydrogen: frequently asked questions

**Is it a medical device?**

No. PRAGMA HYDROGEN is a device for wellness use. It does not replace a consultation with a doctor.

**Is hydrogen inhalation safe?**

In clinical trials, hydrogen inhalation was well tolerated. The generator has 8 safety features that stop it working if a fault occurs. Hydrogen is a flammable gas: do not smoke or use an open flame near the device. People with chronic conditions, pregnant women and children should consult a doctor before use.

## Related topics

[Chronic laryngitis](https://pragmah2.com/en/hydrogen-and-health/chronic-laryngitis/) [Chronic obstructive pulmonary disease (COPD)](https://pragmah2.com/en/hydrogen-and-health/chronic-obstructive-pulmonary-disease-copd/) [Chronic sinusitis](https://pragmah2.com/en/hydrogen-and-health/chronic-sinusitis/) [Cystic fibrosis](https://pragmah2.com/en/hydrogen-and-health/cystic-fibrosis/) [Emphysema](https://pragmah2.com/en/hydrogen-and-health/emphysema/) [Pneumonia](https://pragmah2.com/en/hydrogen-and-health/pneumonia/) [Sleep apnoea](https://pragmah2.com/en/hydrogen-and-health/sleep-apnoea/) [All topics (170)](https://pragmah2.com/en/hydrogen-and-health/)

### Sources and method

Every study we describe links to its publication. See how we read studies and how we assess the strength of the evidence.

[How we read studies](https://pragmah2.com/en/knowledge-base/how-to-read-the-studies/) [Study bank](https://pragmah2.com/en/studies/)

### Any questions?

Call or write to us. We reply within one working day.

[Contact](https://pragmah2.com/en/contact/)
